Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib: a clinical validation studyMahrukh M. Syeda, David Polsky, Jennifer Wiggins et al.|The Lancet Oncology|2021Cited by 96
Development of Novel Mutation-Specific Droplet Digital PCR Assays Detecting TERT Promoter Mutations in Tumor and Plasma SamplesBroderick C. Corless, David Polsky, Gregory Chang et al.|Journal of Molecular Diagnostics|2018Cited by 69
TERT, BRAF, and NRAS Mutational Heterogeneity between Paired Primary and Metastatic Melanoma TumorsGregory Chang, David Polsky, Jennifer Wiggins et al.|Journal of Investigative Dermatology|2020Cited by 22
Validation of Circulating Tumor DNA Assays for Detection of Metastatic MelanomaMahrukh M. Syeda, David Polsky, Jennifer Wiggins et al.|Methods in molecular biology|2019Cited by 12
Plasma cell-free circulating tumor DNA (ctDNA) detection in longitudinally followed glioblastoma patients using <i>TERT</i> promoter mutation-specific droplet digital PCR assays.Christine Cordova, Mahrukh M. Syeda, Broderick C. Corless et al.|Journal of Clinical Oncology|2019Cited by 12